Jia Xingyu, Chen Songfeng, Zhuang Qianjun, Tan Niandi, Zhang Mengyu, Cui Yi, Wang Jinhui, Xing Xiangbin, Xiao Yinglian
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
J Neurogastroenterol Motil. 2023 Apr 30;29(2):145-155. doi: 10.5056/jnm22176.
Achalasia is a primary esophageal motility disorder manifested by dysphagia and chest pain that impair patients' quality of life, and it also leads to chronic esophageal inflammation by food retention and increases the risk of esophageal cancer. Although achalasia has long been reported, the epidemiology, diagnosis and treatment of achalasia are not fully understood. The current clinical dilemma of achalasia is mainly due to its unclear pathogenesis. In this paper, epidemiology, diagnosis treatment, as well as possible pathogenesis of achalasia will be reviewed and summarized. The proposed hypothesis on the pathogenesis of achalasia is that genetically susceptible populations potentially have a higher risk of infection with viruses, triggering autoimmune and inflammation responses to inhibitory neurons in lower esophageal sphincter.
贲门失弛缓症是一种原发性食管动力障碍性疾病,表现为吞咽困难和胸痛,会损害患者的生活质量,还会因食物潴留导致慢性食管炎,并增加患食管癌的风险。尽管贲门失弛缓症早已被报道,但对其流行病学、诊断和治疗尚未完全了解。目前贲门失弛缓症的临床困境主要是由于其发病机制尚不清楚。本文将对贲门失弛缓症的流行病学、诊断治疗以及可能的发病机制进行综述和总结。关于贲门失弛缓症发病机制提出的假说是,遗传易感性人群可能有更高的病毒感染风险,从而引发对食管下括约肌抑制性神经元的自身免疫和炎症反应。